Atrys Health, S.A. (ATRY)
BME
2.53
-0.02 (-0.78%)
Real-time Data
07:00 AM
Day's Range
2.512.58
52 wk Range
2.313.59
Financial Statements - ATRY - Atrys Health, S.A.
Revenue
141.00M▲ 8.5%
Net Income
-100.54M▼ 214.2%Net Margin -71.3%
EBITDA
22.14M▼ 35.2%
Free Cash Flow
-14.07M▼ 38.8%
Income Statement
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|---|---|
| Sales | 141M | 129.97M | 201.56M | 158.36M | 121.01M | 31.39M |
| Cost of Goods | 79.66M | 64.49M | 59.79M | 32.36M | 20.12M | 7.14M |
| Gross Profit | 61.34M | 65.48M | 141.77M | 126M | 100.89M | 24.25M |
 Operating Expense | - | - | - | - | - | - |
| Operating Income | -5.74M | 5.85M | 3M | -3.57M | -12.39M | -2.13M |
| Non-Operating Interest | - | - | - | - | - | - |
| Other Income Expense | - | - | - | - | - | - |
| Pre Tax Income | -56.20M | -34.62M | -33.69M | -26.79M | -24.88M | -5.38M |
| Income Tax | -576K | -1.85M | -2.94M | -839K | -1.68M | 167K |
| Net Income | -100.54M | -32M | -45.89M | -23.40M | -23.24M | -5.54M |
| EPS Basic | - | -0.42 | -0.601 | -0.339 | -0.462 | -0.196 |
| EPS Diluted | - | -0.42 | -0.601 | -0.339 | -0.462 | -0.196 |
| Basic Shares Outstanding | - | 75.92M | 75.81M | 68.20M | 50.28M | 28.31M |
| Diluted Shares Outstanding | - | 75.92M | 75.81M | 68.20M | 50.28M | 28.31M |
| Ebit | -37.17M | -12.05M | -649K | -12.26M | -19.12M | -3.03M |
| Ebitda | 22.14M | 34.17M | 33.27M | 21.42M | 3.17M | 3.11M |
| Net Income Continuous Operations | -56.20M | -33.47M | -33.69M | -26.79M | -24.88M | -5.38M |
| Minority Interests | 251K | 232K | 307K | 258K | -12K | 0 |
| Preferred Stock Dividends | 0 | 0 | 0 | 0 | 0 | 0 |
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
